Ruofei Du
Associate Professor
faculty
Biostatistics, College of Public Health
15 h-index
48 pubs
802 cited
Research Areas
Biography and Research Information
OverviewAI-generated summary
Ruofei Du's research focuses on the application of biostatistical methods to public health challenges, particularly in the area of cancer screening and infectious diseases. Recent work includes population-based evaluations of human papillomavirus (HPV) and cytology co-testing for cervical cancer screening in the United States, supporting the shift towards primary HPV screening. Du has also investigated the performance of different HPV assays in real-world settings. Additionally, their research portfolio extends to SARS-CoV-2 seroprevalence surveys and the study of DNA repair mechanisms in cellular replication. Du has published 50 papers, accumulating 794 citations, and holds an h-index of 15. Collaborations within the University of Arkansas for Medical Sciences include work with J. Craig Forrest, Catherine Kirkpatrick, Shana M. Owens, and Joshua L. Kennedy, with whom Du shares two publications each.
Metrics
- h-index: 15
- Publications: 48
- Citations: 802
Selected Publications
-
Risk Factors for a Primary Cesarean Delivery in Pregnancies Complicated by Pregestational Diabetes (2026)
-
Contributing Factors to Delay of Adjuvant Postsurgical Radiation for Malignant Brain Tumors (2025)
-
Implementation of an Order Set Prior to Delivery Discharge for Postpartum Glucose Testing in Gestational Diabetes: Gaps in Follow-Up and Opportunities for Improvement (2025)
-
Geranylgeranyl Transferase Inhibitors Mitigate Intestinal Radiation Toxicity (2025)
-
Capacity to address determinants of health among a social justice coalition in the United States (2025)
-
Sex-specific immune alterations in mice following long-term simulated microgravity and chronic irradiation (2025)
-
Perinatal Outcomes and Management of Umbilical Vein Varix: A Comprehensive Review of 392 Cases (2025)
-
Caregiver restrictions on child access to tobacco in the home and home Smoking/Vaping bans among Black/African American women caregivers who smoke and live in Resource-limited, rural areas (2024)
-
TimeNorm: a novel normalization method for time course microbiome data (2024)
-
Using Concept Mapping to Identify Community Partners’ and Researchers’ Perceptions of Social Justice: A Path Toward Eliminating Chronic Disease Disparities (2024)
-
Long-term sedation with remimazolam besylate versus propofol in critically ill patients during invasive mechanical ventilation: a study protocol for a multicenter randomized non-inferior trial (2023)
-
Unchanged PCNA and DNMT1 dynamics during replication in DNA ligase I-deficient cells but abnormal chromatin levels of non-replicative histone H1 (2023)
-
Maternal comorbidity index and severe maternal morbidity among medicaid covered pregnant women in a US Southern rural state (2023)
-
Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts (2023)
-
Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts (2022)
Grants & Funding
- FOOD AS MEDICINE: ADDRESSING SOCIAL DETERMINANTS OF HEALTH (FOOD INSECURITY) TO EFFECT CLINICAL OUTCOMES (CEAL) Westat - Pass Through: Westat Co-Investigator
- Center for Native American Environmental Health Equity Research NIH, EPA Other Key Personnel
- Center for Research, Health and Society NIH Co-Investigator
- Understanding Risk Gradients from Environment on Native American Child Health Trajectories: Toxicants, Immunomodulation, Metabolic syndromes, & Metals Exposure NIH/Office of the Director - Pass Through: University of New Mexico Principal Investigator
- UNM Metal Exposure Toxicity Assessment on Tribal Lands in the Southwest (METALS) Superfund Research Program NIH/Nat. Inst. of Environmental Health Sciences - Pass Through: University of New Mexico Principal Investigator
- DISCOVAR:Disparities in Immune Response to SARS-CoV-2 in ARkansas NIH Co-Investigator
- UNM Metal Exposure Toxicity Assessment on Tribal Lands in the Southwest (METALS) Superfund Research Program NIH/Nat. Inst. of Environmental Health Sciences - Pass Through: University of New Mexico Principal Investigator
- Preventing immune system dysregulation during deep-space missions by Tocofexol, a modified isomer of vitamin E - AA request National Aeronautics & Space Administration - Pass Through: Arkansas Space Grant Consortium Other Key Personnel
Collaboration Network
Top Collaborators
Jack Cuzick
Queen Mary University of London (GB)
5 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Cosette M. Wheeler
New Mexico Cancer Center (US)
5 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Walter Kinney
4 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Ruth McDonald
4 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Michael Robertson
New Mexico Cancer Center (US)
4 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Ji‐Hyun Lee
University of Florida (US)
4 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- A weight Jackknife approach utilizing linear model based-estimators for clustered data
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Debbie Saslow
3 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Mark H. Stoler
Becton Dickinson (United States) (US)
3 shared publications
- Uptake of co-testing with HPV and cytology for cervical screening: A population-based evaluation in the United States
- Impact of HPV testing in opportunistic cervical screening: Support for primary HPV screening in the United States
- Comparing the performance of 2 human papillomavirus assays for a new use indication: a real-world evidence-based evaluation in the United States
Richard C. Lauer
New Mexico Cancer Center (US)
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Marc Barry
University of Utah (US)
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Tracey L. Smith
Rutgers Cancer Institute of New Jersey
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Andrew Maltez Thomas
Universidade de São Paulo (BR)
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Jin Wu
UNM Comprehensive Cancer Center
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Arpit Rao
Baylor College of Medicine (US)
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Andrey S. Dobroff
New Mexico Cancer Center (US)
3 shared publications
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
- Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: From experimental discovery to validation in two independent patient cohorts
- Author response: Dysregulation of the PRUNE2/PCA3 genetic axis in human prostate cancer: from experimental discovery to validation in two independent patient cohorts
Similar Researchers
Based on overlapping research topics
Mehedi Hassan
University of Arkansas at Fayetteville
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy
Weber, Kari
University of Arkansas for Medical Sciences
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy
Velimir Petrović
University of Arkansas for Medical Sciences
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy
Joshua C. McKinnon
University of Arkansas for Medical Sciences
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy
Donald B. McCormick
University of Arkansas for Medical Sciences
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy
Sandra M Meredith-Neve
University of Arkansas for Medical Sciences
Public Health Research
COVID-19 epidemiological studies
Vaccine Coverage and Hesitancy